WeVote
Log In

Bill

Bill

HB 625

Health insurance; limit on cost-sharing payments for prescription drugs under certain plans.

2026 Regular Session Introduced by Dan Helmer and 1 co-sponsor

HB 625 caps prescription drug cost-sharing payments in Virginia health insurance plans to improve medication affordability and accessibility for patients.

Acts of Assembly Chapter text (CHAP0641)
0
WeVote Research Nonpartisan
Bill Summary · HB 625

Legislative bill overview

HB 625 would establish limits on out-of-pocket cost-sharing (copays, coinsurance, and deductibles) that individuals must pay for prescription drugs under certain health insurance plans in Virginia. The bill aims to make prescription medications more affordable by capping the financial burden on patients at the point of sale.

Why is this important

Prescription drug costs are a significant healthcare expense for many Virginians, and high cost-sharing can prevent patients from filling or taking medications as prescribed, worsening health outcomes. By limiting cost-sharing, the bill could improve medication adherence and reduce overall healthcare costs by preventing disease complications, though it may also increase insurance premiums or reduce insurer coverage options.

Potential points of contention

  • Cost-shifting concerns: Insurers may offset lower patient cost-sharing by raising premiums, reducing benefits in other areas, or limiting which drugs are covered
  • Market impact: Stricter cost-sharing limits could reduce health plan options available to Virginia consumers or cause insurers to exit the market
  • Scope ambiguity: The bill's application to "certain plans" is vague—unclear which plan types are covered and whether it applies to self-insured employer plans or only regulated insurance products

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.